PSO HNS Jubilee Midyear Convention · PSO-HNS Jubilee Midyear Convention O n behalf of the Board of Trustees of the Philippine Society of Otolaryngology - Head and Neck Surgery let

PSO-HNS Jubilee Midyear Convention


Messages 3 - 6

PSO-HNS Board of Trustees 2016 7

Organizing Committee 8

Conference Guidelines 9

Vicinity Map 10

Floor Map 11

Program at a Glance 12 - 13

Program of Activities 14 - 20

Plenary Abstracts 21 - 42

Foreign Speakers’ Directory 43

Local Speakers’ Directory 44 - 45

Sponsors’ & Exhibitors’ Directory 46 - 51

Acknowledgement 52


I convey my heartfelt greetings and congratulations to the organizers

and members of the Philippine Society of Otolaryngology- Head and

Neck Surgery (PSO-HNS) on your 60th Jubilee Midyear Convention on

April 15-17, 2016 at the EDSA Shangri-La Hotel, Mandaluyong City with the

theme: “PSO-HNS Trends at 60: Diagnostics, Therapeutics and Prevention”

The efforts of the PSO-HNS to work towards the goal of advancing

your field of specialization through one encompassing gathering, is truly admirable. The unity displayed by

members of your organization speaks of how even in the most complex of issues in the global health milieu we

can discover our respective niches and contribute significantly in creating effective, lasting solutions.

The Philippine Medical Association (PMA) is honoured to be a part of your distinguished work, and as

President, I commend your continued commitment to providing your members with the latest updates on

current issues in the field of otolaryngology-head and neck surgery given the challenges posed by the ASEAN

Integration. I trust that such efforts redound to enhance and promote camaraderie among your participants who

are given the opportunities for learning and improvement in knowledge and skills regarding the practice of your

specialty. Remember to strengthen your Organization from within even as you continue to hurdle challenges

from outside

May this event inspire excellence in all of you, and strengthen your core as an organization that

constantly strive for advancement and the highest standards of our profession. Rest assured, that the PMA as the

umbrella organization of all medical organizations in the Philippines, shall be behind PSO-HNS and support you

in all your worthy undertakings.

I send my fondest wish for a fruitful and memorable Convention for all the delegates. Mabuhay!

"We are ONE PMA: Empowering the Filipino Physician for Nation Building"

MARIA MINERVA P. CALIMAG, M.D., PhD, FPBA

President 2014 - 2016

Philippine Medical Association


O n behalf of the Board of Trustees of the Philippine Society of

Otolaryngology - Head and Neck Surgery let me welcome you all

to the celebration of our 60th Anniversary. It is indeed a great

honor and privilege to be your President on this banner year filled with so

many significant milestones.

The theme “ A Legacy of Brilliance” draws our attention to our

historic past where the original “Heroic Nine” now represented by the last man standing and leader of our

founding fathers Dr. Tierry Garcia provided a clear vision of why a separate and distinct specialty of medicine

and surgery such as ours will well serve the needs of patients in need of competent, quality care in the Ear Nose

and Throat – Head and Neck Surgery. More important is how this legacy continues to provide a bright future

upon which the next generation of otolaryngologists in our country will be proud to build upon. As we have

grown from 9 to 694 fellows it is but fitting that we harness our passion for excellence, honor and integrity to

meet the challenges of an increasingly globalized health care delivery platform, leverage our innate spirit of

innovation and explore the ever exciting new frontiers to improve our understanding of the breadth and depth of

our specialty even as we embark on new paths towards stronger advocacy for better health among our fellow

Filipinos. Let us be reminded that equity in health for our poor and marginalized brothers remains a goal which

will require our fervent and dedicated efforts. Let us be mindful of the fact that while most of us enjoy the

wonders of modern technology, affordability, availability as well as accessibility to most of these advanced

devices and services by the majority of our countrymen will require our concerted efforts in extending our

expertise such that those who really are in need can receive this care.

Again let me thank and congratulate the hardworking team of the Organizing Committee and the

Scientific Committee headed by Dr. Dan Poblete and Dr. Don Jurado respectively for this superb offering for the

jubilee midyear congress.

CHARLOTTE M. CHIONG, M.D.

President

Philippine Society of Otolaryngology-Head & Neck Surgery


T he Philippine Board of Otolaryngology-Head and Neck

Surgery greets and congratulates the officers and organizing

committee of the Philippine Society of Otolaryngology-Head

and Surgery in this year’s midyear convention with the theme, “ PSO-

HNS Trends at 60: Diagnostics, Therapeutics, and Prevention”.

It will surely be worth our time since it will be another

successful event for learning, especially with the lineup of high quality speakers both foreign and local.

The topics will be of interest to all since it will deal on the very basic aspects of our ENT-HNS practice.

However, I hope everyone will participate and enjoy the social events with renewal of friend-

ship which is customary in our convention. Thank you and mabuhay!

RODOLFO P. NONATO, M.D.

President

Philippine Board of Otolaryngology-Head & Neck Surgery


A nostalgic glimpse of the past, a positive outlook of the fu-

ture and festive celebrations await the 60th Year of the

Philippine Society of Otolaryngology – Head and Neck

Surgery, Inc. “Our 60th Diamond Jubilee Year 2016”.

“Our celebrations started last February 17, 2016, exactly on the

date the society was founded in 1956 by the Heroic Nine – The Fellows

Jubilee Ball at the Rizal Ballroom of the Makati Shangri-La Manila with the theme “PSO-HNS: A

Legacy of Brilliance”.

The Founding President Dr. Tierry Garcia leads the guests as we dine together, viewed

audiovisuals, pay tribute to our fellows and celebrate with our colleagues.

Secondly, our fellows, board diplomates and residents will be treated to a scientific-social

celebration on April 15 – 17, 2016 at the Edsa Shangri-La Hotel for a three-day Jubilee Midyear

Convention with the theme “ORL-HNS: Diagnostics, Therapeutics and Prevention”.

After the convention, the Society’s Advocacy Committee will initiate the ENT-Head and Neck

Programs which will be of value to our countrymen.

DANILO A. POBLETE, M.D.

Overall Convention Chair



BOARD OF TRUSTEES

Charlotte M. Chiong., MD

President

Melfred L. Hernandez, MD

Vice President

Agnes T. Remulla, MD

Secretary

Elmo R. Lago, MD

Treasurer

Abegayle Machelle M. Perez-Chua, MD

Auditor

Arsenio Claro A. Cabungcal, MD

Robert R. Dy, MD

Jay Remy P. Gonzalez II, MD

Erasmo Gonzalo D.V. Llanes, MD

Danilo A. Poblete, MD

Herman Melvin P. Sirilan, MD

Trustees

Armando M. Chiong Jr., MD

Immediate Past President

Rodolfo P. Nonato, MD

President, PBO-HNS

CHAPTER PRESIDENTS

Jose B. Orosa III, MD

Northern Luzon

Nelson N. Magno, MD

Central Luzon

Ramon V. Carmona Jr., MD

Southern Tagalog

Melvin G. Berin, MD

Bicol

Mervin Louis C. Varona, MD

Central Eastern Visayas

Herman Melvin P. Sirilan, MD

Western Visayas

J. Gabriel C. De Borja, MD

Southern Mindanao

Vincent Mark M. Jardin, MD

Northern Mindanao


Charlotte M. Chiong, MD

Honorary Chair

Danilo Poblete, MD

Overall Convention Chair

COUNCIL OF ADVISERS

Remigio I. Jarin, MD

Vicente T. Chiong, MD

Jacob S. Matubis, MD

Benito L. Uy, MD

Natividad A. Almazan, MD

Cesar Anthony P. Yabut, MD

STEERING COMMITTEE

Alexander C. Cabungcal, MD

Joseph Arnold R. Darvin, MD

Adonis B. Jurado, MD

Teresa Paz G. Pascual, MD

Joel A. Romualdez, MD

Deo H. Talanay, MD

WAYS AND MEANS

Danilo A. Poblete, MD


Deo H. Talanay, MD

Joanna F. Flores, MD

SCIENTIFIC PROGRAM

Adonis B. Jurado, MD

Mary Aimee O. So-Singson, MD

Margaret C. Lim-Jurado, MD


Ma. Clarissa S. Fortuna, MD


Joselito F. David, MD

Cecilia Gretchen S. Navarro-Locsin, MD

Lyra V. Veloro,MD

Antonio H. Chua, MD

INVITATIONS/ REGISTRATION

Robert R. Dy, MD

John V. Silva, MD

Adrian F. Fernando, MD

Alfred B. Balagtas III, MD

Archie Brian C. Ramos, MD

Danilo D. Deveza Jr. , MD

Dominador Enrique E. Gomez, MD

Mary Jane S. Mallillin, MD

Mary Rose Adeline M. Guinto, MD

Michael S. Loo, MD

Vangie S. Sumulong, MD

ADVOCACY & PUBLICITY


Robert R. Dy, MD

Rene Louie C. utierrez, MD

COFFEE TABLE BOOK

Maria Elaine D. Villanueva, MD

Frederick Y. Hawson, MD

Jose B. Orosa III, MD

Felicidad B. Mendoza-Remulla, MD

John Felmore A. Juridico, MD

SOUVENIR PROGRAM

Danilo D. Deveza Jr., MD

PHYSICAL & TECHNICAL ARRANGEMENT

Joseph Arnold R. Darvin, MD

Rodney Oliver J. Aragon, MD

Elmer M. Dela Cruz, MD

Maria Elaine D. Villanueva, MD

Patrick Joseph A. Pardo, MD

Conrado Donato A. Pabico Jr., MD

Theodore M. Carvajal, MD

BOOTHS & EXHIBITS

Mary Aimee O. So-Singson, MD

Olma C. Carpiso, MD

MEMORABILIA EXHIBITS

Deo H. Talanay, MD

Carlo A. Nofuente, MD

Michelle Angelica Cruz-Daylo, MD

PSO-HNS HYMN

Mary Arlene A. Bongosia, MD

JUBILEE BALL

Teresa Paz G. Pascual, MD

Deo H. Talanay, MD

SOCIALS

Rebecca R. Feliciano, MD

Emma B. Guevara, MD

Johanna Co-Dy Lim, MD

Arnelle Y. Qiuambao, MD

Maria Cristina B. Viceral

PSO-HNS ADVOCACIES CARAVAN

Gerald D. Singson, MD


Edmund T. Ong, MD

SECRETARIAT

Mia Filipina B. Mabuti

Sharon T. Barraquiel

Mellissa B. Martinez

Francisco H. Tutaan


IDENTIFICATION CARDS

Upon registration, an attendee is given an ID card.

This must be worn at all times for admission to the

plenary and symposia sessions and official social

functions.

ID cards are color coded according to the

participants’ wit:

YELLOW Organizing Committee

Secretariat

GREEN Board of Trustee

Chapter President

PBO - HNS Director

PSO - HNS Past President

Senior Member

BLUE Delegate

RED Speaker

ORANGE Day Registrant

PURPLE Sponsor/ Exhibitor

Accompanying Person

Please approach members of the organizing

committee or the secretariat staff for assistance.

SCIENTIFIC PROGRAM

Please read the delegates’ programme section to

get detailed information on the schedule. Please

be punctual, as sessions will commence on time.

Smoking is strictly prohibited in all session rooms.

Absolute silence is requested throughout the

speakers’ presentations. Please switch to silent

mode all hand held phones.

LUNCH & DINNER SYMPOSIA

Meal stubs will be collected by the waiters prior to

being served. Please do not lose your stubs.

CONFERENCE SECRETARIAT ROOM

The conference secretariat room is located at

Lubang Room. It will be open on April 15 - 17,

2016, from 8:00 AM to 5:00 PM.


1 Garden Way

Ortigas Center Center

Mandaluyong City, Philippines


TOWER WING BALLROOMS

Plenary: Isla Ballroom

TOWER WING FUNCTION ROOMS

Secretariat: Lub ang

Registration: Lob b y

Speakers’ Viewing Room: Basilan

Memorabilia Room: Mactan 1

Lobby


7:30 AM- 5:00 PM REGISTRATION

Sponsored by: UniCARE - United Laboratories, Inc.

9:00 AM - 10:00 AM OPENING CEREMONIES

Messages from the Pioneers

10:00 AM - 10:20 AM SPECIAL SYMPOSIUM

10:20 AM - 10:35 AM OPENING OF BOOTHS & EXHIBITS

10:35 AM - 10:50 AM COFFEE BREAK

10:50 AM - 12:20 PM PLENARY 1: Laryngology

12:20 PM - 1:50 PM LUNCH SYMPOSIUM 1

Sponsored by: United American Pharmaceuticals, Inc.

1:50 PM - 3:20 PM PLENARY 2: Allergy

3:20 PM - 3:35 PM COFFEE BREAK

3:35 PM - 5:05 PM PLENARY 3: Molecular Diagnostics

7:00 PM - 8:00 PM DINNER SYMPOSIUM 1


8:00 PM - 12:00 MN GALA NIGHT

Sponsored by: PSO-HNS

DAY 1: April 15, 2016 (Friday)

Diagnostics in ENT Diseases


9:00 AM - 10:00 AM PLENARY 4: Sleep


10:15 AM - 11:15 AM PLENARY 5: Rhinology

11:15 AM - 12:15 PM PLENARY 6: Maxillofacial Surgery

12:15 PM - 1:45 PM LUNCH SYMPOSIUM 2

Sponsored by: Takeda

1:45 PM - 3:15 PM PLENARY 7: Head and Neck


3:30 PM - 5:00 PM PLENARY 8: Facial Plastic Surgery

5:00 PM - 7:00 PM

DAY 2: April 16, 2016 (Saturday)

Therapeutics

9:00 AM - 10:30 AM PLENARY 9: Otology & Audiology


10:45 AM - 12:15 PM PLENARY 10: OSA & Siliconoma

12:15 AM - 1:45 PM LUNCH SYMPOSIUM 3

Sponsored by: Natrapharm

1:45 PM - 2:15 PM SPECIAL SYMPOSIUM

2:15 PM - 3:35 PM PLENARY 11:


3:50 PM - 5:30 PM PLENARY 12: Legal Issues

7:30 PM - 8:30 PM DINNER SYMPOSIUM 2

Sponsored by: A. Menarini Philippines, Inc.

8:30 PM - 12:00 MN FELLOWSHIP NIGHT


DAY 3: April 17, 2016 (Sunday)

Preventive Measures & Advocacies


7:30 AM - 5:00 PM REGISRATION

Sponsored by: UniCARE - United Laboratories, Inc.

9:00 AM - 10:00 AM OPENING CEREMONIES

Messages from the Pioneers

10:00 AM - 10:20 AM SPECIAL SYMPOSIUM: The PMA, the PQF, the Profession & the

ePortfolio

Ma. Minerva P.Calimag, M.D., PhD, FPBA

10:20 AM - 10:35 AM OPENING OF BOOTHS & EXHIBITS


10:50 AM - 12:20 PM PLENARY 1: Laryngology

Chair: Ma. Clarissa S. Fortuna, M.D.

Co-Chair: William L. Lim, M.D.

Diagnosing Abnormal Vocal Fold Lesions in Patients with Cancer &

Dysplasia

James Alexander Burns, M.D. (USA)

Office Based Laryngeal Surgery


12:20 PM - 1:50 PM LUNCH SYMPOSIUM 1:

The Winning Formula to Boost the Immune Defence: Sodium Ascorbate plus

Zinc

Gil M. Vicente, M.D. (Philippines)

ZincPlus Tablet Technology

Kennie U. Dee, PhD (Philippines)


DAY 1: DIAGNOSTICS IN ENT DISEASES April 15, 2016 (Friday)


1:50 PM - 3:20 PM PLENARY 2 : Allergy Sponsored by:

Pharex

Chair: Peter R. Jarin, M.D.

Co-Chair: Rodante A. Roldan, M.D.

Allergy Testing (Skin-Prick Test & Blood Tests)

Madeliene Sumpaico, M.D. (Philippines)

Local Allergic Rhinitis: A Diagnostic Challenge

Madeliene Sumpaico, M.D. (Philippines)

Pediatric Allergic Rhinitis: Current Approach and Future Possibilities

Steven Lawrence Goudy, M.D. (USA)


3:35 PM - 5:05 PM PLENARY 3 : Molecular Diagnostics

Chair: Joel A. Romualdez, M.D.

Co-Chair: Arsenio Claro A. Cabungcal, M.D.

Molecular Diagnostics: Challenges for Routine Use in the Clinics

Gretchen S. Navarro-Locsin, M.D. (Philippines)

Genetic Determinants of Hearing Impairment and Otitis Media

Regie Lyn P. Santos-Cortez, M.D., PhD (USA)

Molecular Pathology of Head & Neck Cancer: Implications for Diagnosis,

Prognosis, & Treatment

Ann Margaret V. Chang, M.D. (Philippines)

7:00 PM - 8:00 PM DINNER SYMPISIUM 1 : Allergic Rhinitis: Change is in the Air

Ma. Lourdes B. Enecilla, M.D. (Philippines)

Joel A. Romualdez, M.D. (Philippines)


8:00 PM - 12:MN GALA NIGHT


cont. Day 1


9:00 AM - 10:00 AM PLENARY 4: Sleep Sponsored by: Ino-

va

Chair: Keith Romeo A. Aguilera, M.D.

Co-Chair: Maria Patricia Ann T. Puno, M.D.

Current Therapeutic Intervention for OSA: How Effective are They?

Agnes Tirona-Remulla, M.D. (Philippines)

Oral Appliances for OSA

Emma Natividad, M.D. (Philippines)


10:15 AM - 11:15 AM PLENARY 5: Rhinology

Chair: Antonio H. Chua, M.D.

Co-Chair: Ma. Lourdes B. Enecilla, M.D.

SCIT and SLIT for Allergic Rhinitis


Pediatric Chronic Sinusitis: What the Literature Shows, and How I Practice


Balloon Sinuplasty

Benjamin S.A. Campomanes Jr., M.D. (Philippines)

DAY 2: THERAPEUTICS April 16, 2016 (Saturday)


11:15 AM - 12:15 PM PLENARY 6: Maxillofacial Surgery

Chair: Alexander C. Cabungcal, M.D.

Co-Chair: Joselito F. David , M.D.

New Developments & Innovations in Maxillofacial Surgery

Peter Aylifee, M.D. (United Kingdom)

Update on Cleft Lip and Palate Surgery: From Data to Outcomes


Maxillofacial Reconstruction

Peter Aylifee, M.D. (United Kingdom)

12:15 AM - 1:45 PM LUNCH SYMPOSIUM 2: Laryngopharyngeal Reflux Today: Updates on

Pathology, Diagnosis & Treatment

Rebecca R. Feliciano, M.D. (Philippines)

Sponsored by: Takeda

1:45 PM - 3:15 PM PLENARY 7 : Head and Neck Surgery Sponsored by: Bio-

medis

Chair: Samantha S. Castañeda, M.D.

Co-Chair: Jose B. Orosa III, M.D.

The Role of Technology in Patient Specific Medicine: Trans-oral Robotic

Surgery and Medical Modelling for Bony Reconstruction

Michael V. Medina, M.D. (USA)

The Role of Technology in Thyroid nodules and Malignancy: Molecular

Testing and Continuous Nerve Monitoring

Michael V. Medina, M.D. (USA)

Panel Discussion: Synovial Sarcoma of the Hypopharynx

Arsenio Claro A. Cabungcal, M.D. (Philippines)

Katrina P. Ferrera M.D., (Philippines)

Erland del Rosario, M.D. (Philippines)

Michael Mejina, M.D. (Philippines)


cont. Day 2


9:00 AM - 10:30 AM PLENARY 9: Otology & Audiology

Chair: Norberto V. Martinez, M.D.

Co-Chair: Joel A. Romualdez, M.D.

Decreasing the Incidence of AOM

Maria Rina Reyes-Quintos, M.D. (Philippines)

Noise Induced Hearing Loss & Tinnitus Prevention Works

William Hal Martin, M.D., PhD (Singapore)

Tinnitus: How to Start a Management Program

William Hal Martin, M.D., PhD (Singapore)

Strides at Home: History &Updates on Newborn Hearing Screening in the

Philippines

Rosario R. Ricalde, M.D. (Philippines)

DAY 3: PREVENTIVE MEASURES & ADVOCACIES April 17, 2016 (Sunday)

3:30 PM - 5:00 PM PLENARY 8: Facial Plastic Procedures

Chair: Levi John G. Lansangan, M.D.

Co-Chair: Mark Arjan R. Fernandez, M.D.

Botulinum Toxin in ORL

Jaime Anthony A. Arzadon III, M.D. (Philippines)

F-POP: Facial Plastic Office Procedures

Joseph Amado C. Galvez, M.D. (Philippines)

A Decade of Goretex Rhinoplasty in the Philippines

Eduardo C. Yap, M.D. (Philippines)

5:00 PM - 7:00 PM

cont. Day 2



10:45 AM - 12:15 PM PLENARY 10 : OSA & Siliconoma

Chair: Romulus Roberto Peter A. Instrella, M.D.

Co-Chair: Deo H. Talanay, M.D.

Management and Prevention of Morbidities of Silicone Infection or

Siliconoma

Corazon Collantes-Jose, M.D. (Philippines)

Lifestyle Modification for OSA

Michael Alexius A. Sarte, M.D. (Philippines)

Safety in the Workplace: Screening for OSA

Virginia S. De los Reyes, MD, MHPEd, FPSSM, DWASM (Philippines)

12:15 PM - 1:45 PM LUNCH SYMPOSIUM 3: Chronic Cough & Acid: From the Eyes of a

Gastroenterologist

Frederick Dy, M.D., FPCP, FPSG, FPSDE

Sponsored by: Natrapharm

1:45 PM - 2:15 PM SPECIAL SYMPOSIUM : Nasal Stem Cells Research, Understanding the

Role of Nasal Epithelium in Common Nasal Diseases

De-Yun Wang, M.D. (Singapore)

2:15 PM - 3:35 PM PLENARY 11 :

Chair: Lyra V. Veloro, M..D.

Co-Chair: Mary Arlene A. Bongosia, M.D.

Preventing Foreign Body Aspiration & Ingestion

Mary Jane C. Tipayno-Lubos, M.D. (Philippines)

Taking Steps Towards Cleaner Air and a Healthier Nose

Ma. Lourdes B. Enecilla, M.D. (Philippines)

When the Voice Fails: Identifying & Addressing Factors that

Compromise Voice Use in the Workplace

Carla Krishnan A. Cuadro, MRS-SP, CSP-PASP (Philippines)

Frederick Y. Hawson, M.D. (Philippines)

Melfred L. Hernandez., M.D. (Philippines)

Fortuna Corazon A. Aberin-Roldan, M.D. (Philippines)

cont. Day 3



3:50 PM - 5:30 PM PLENARY 12 : Legal Issues

Chair: Atty. Teresa Paz G. Pascual, M.D.

Co-Chair: Jose M. Acuin, M.D.

Physicians' Rights

Atty. Teresa Paz G. Pascual, M.D. (Philippines)

Sentinel & Adverse Events: Averting a Crisis

Atty. Karen Jiz, M.D. (Philippines)

Informed Consent

Atty. Ivy D. Patdu, M.D. (Philippines)

Updates on Medical Malpractice/ Breach of Confidentiality

Atty. Joel U. Macalino, M.D. (Philippines)

7:30 PM - 8:00 PM DINNER SYMPOSIUM 2: Treatment of Allergic Rhinitis: A Review of

the Newest Antihistamine Drug Bilastine

De-Yun Wang, M.D. (Singapore)

Sponsored by: A. Menarini Philippines, Inc.

8:00 PM - 12:00 MN FELLOWSHIP NIGHT


cont. Day 3


PLENARY 1: Laryngology April 15, 2016 (10:50 AM - 12:20 PM)

10:50 AM - 11:35 AM

DIAGNOSING ABNORMAL VOCAL FOLD LESIONS IN PATIENTS WITH CANCER

AND DYSPLASIA


Accurately diagnosing abnormal vocal fold lesions in patients with early glottic cancer and

dysplasia remains a challenge. Concern for vocal fold scarring and resulting dysphonia with biopsy/

excision of the lesion is balanced against the need to treat a pre-malignant lesion before it becomes

invasive and to thoroughly treat and follow invasive cancer and assess the post-operative wound.

Successful management of recurrent vocal fold dysplasia and post-surgery wounds requires balancing

treatment goals (disease regression and voice preservation and/or restoration) with the morbidity of the

intervention.

This lecture will describe the use of subepithelial saline infusion and full-thickness microflap

biopsy techniques in diagnosing abnormal vocal fold lesions. Diagnostic accuracy is improved when

representative full-thickness biopsies are obtained, and voice function is optimized when the vocal fold

layered microstructure is preserved. Additionally, this lecture will present findings during wound

healing in a cohort of patients who underwent transoral angiolytic laser surgery for early glottic cancer

including the incidence of abnormal and worrisome endoscopic findings on exam that warrant further

intervention. Post-surgical tissue granulation tissue and eschar can heal without additional surgical

intervention, but biopsy is warranted for persistently abnormal-appearing wounds.


PLENARY 1: Laryngology April 15, 2016 (10:50 AM - 12:20 PM)

11:35 AM - 12:20 PM

OFFICE BASED LARYNGEAL SURGERY James Alexander Burns, M.D. (USA)

Angiolytic laser treatment, which targets microvasculature of papilloma and dysplasia, provides

an innovative way to control disease and preserve voice in adult patients. Office-based angiolytic laser

treatment of papilloma and dysplasia was a key innovation since it obviated the need for on-going

general anesthetic interventions in a majority of patients. The fiber-based delivery of angiolytic lasers

(KTP) allows for treatment of limited laryngeal disease in awake patients with topical anesthesia.

A recent retrospective study suggests an association between early vocal cord medialization

injection and a reduced need for open neck laryngeal framework surgery in patients with persistent

unilateral vocal fold immobility. In hospitalized patients in whom the injury is suspected and

diagnosed, timely bedside medialization injection may have benefit beyond the immediate reduction in

aspiration risk and improved ability to cough and communicate. Our current treatment algorithm for

patients with unilateral vocal fold immobility includes early injection of restylane into the paraglottic

space to improve glottic function.

This lecture will present specific details of how to perform office-based laryngeal procedures

such as laser ablation of papilloma and dysplasia and injection medialization. Indications for including

office-based procedures within the overall treatment strategy for patients with vocal fold immobility and

epithelial proliferative disorders will be presented.


PLENARY 2: Allergy

April 15, 2016 (1:50 PM - 3:20 PM)

1:50 PM - 2:20 PM

ALLERGY TESTING (SKIN-PRICK TEST & BLOOD TEST) Madeliene Sumpaico, M.D. (Philippines)

2:20 PM - 2:50 PM

LOCAL ALLEGRIC RHINITIS: A DIAGNOSTIC CHALLENGE Madeliene Sumpaico, M.D. (Philippines)

2:50 PM - 3:20 PM PEDIATRIC ALLERGIC RHINITIS: CURRENT APPROACH AND FUTURE POSSIBILITIES


Allergic rhinitis is a common problem affecting children of all ages, and is a significant concern for

parents. Often it is difficult to discern the etiology of rhinitis in children, as there are likely multiple

overlapping causes of rhinorrhea. Many of pediatric patients with rhinitis have been treated with

multiple medications prior to their appointment with an otolaryngologist. The impact of rhinitis in

children is significant to patients and caregivers quality of life and cost to the health system. Identifying

the etiology of rhinitis in a cost effective manner is important, and specifically identifying allergic rhinitis

is key, as this is the most treatable. Current therapies revolve around avoidance, nasal hygiene and

pharmacotherapy as first line treatments. Additional consideration for allergy testing and treatment can

be considered for refractory cases, using standard subcutaneous therapy or sublingual therapy. Lastly,

there are potential immunomodulary drugs that may prove to be beneficial in the treatment of these

patients.


PLENARY 3:

April 15, 2016 (3:35 PM - 5:05 PM)

3:35 PM - 4:00PM

MOLECULAR DIAGNOSTICS: CHALLENGES FOR ROUTINE USE IN THE CLINICS Gretchen S. Navarro-Locsin, M.D. (Philippines)

Molecular techniques are important for clinical diagnostics in many disciplines. Progressive and

rapid development of molecular diagnostics such as large-scale whole-genome sequencing and other

“omics” technologies has led to their use in fields as varied as infectious disease, allergology, and

oncology. In oncology, for example, use of molecular diagnostics has led to the discovery of a large

number of pathogenic driver mutations associated with cancer cells. These, together with genetics-

related and idiosyncratic tumor vulnerabilities, have identified new targets for current and next

generation molecular therapeutic drugs to treat defined, genetically stratified subgroups of patients with

cancer. Molecular infectious disease testing allows rapid test results which facilitate detection of

outbreaks and newly emerging strains. It provides sensitive, specific identification of resistant organisms

and quantifiable correlation to disease severity, all of which contribute to timely therapeutic clinical

decisions and early infection control interventions. There are, however, challenges before molecular

diagnostics then be widely adopted for routine clinical use. These include, among others, performance of

the molecular assay, association of the results with a clinical endpoint, and demonstration of the clinical

usefulness of such associations. This presentation discusses these challenges and their implications for

practicing clinicians.


PLENARY 3:

April 15, 2016 (3:45 PM - 5:15 PM)

4:00 PM - 4:40 PM

GENETIC DETERMINANTS OF HEARING IMPAIRMENT AND OTITIS MEDIA Regie Lyn P. Santos-Cortez, M.D., PhD (USA)

The talk will review the genetics of hearing impairment and otitis media, as examples of how

genetic studies can illuminate the pathophysiology of otorhinolaryngologic diseases.

4:40 PM - 5:05 PM

MOLECULAR PATHOLOGY OF HEAD AND NECK CANCER: IMPLICATIONS FOR

DIAGNOSIS, PROGNOSIS, AND TREATMENT Ann Margaret V. Chang, M.D. (Philippines)

Tumors of the head and neck comprise a wide spectrum of heterogeneous neoplasms for which

biomarkers are becoming indispensible aids to earlier diagnosis, risk assessment and therapy response.

Because of the heterogeneity of head and neck tumors, the integration of multiple selected markers in

association with the histopathologic features is advocated for risk assessment and prognostication. The

use of biomarkers is paving the way for a more personalized approach to medicine based on predictive

markers linked to drug response. It is with renewed hope that these biomarkers will result in the

improvement of treatment outcomes and avoidance of unnecessary treatment in selective carcinomas of

the head and neck.


PLENARY 4: Obstructive Sleep Apnea

April 16, 2016 (9:00 AM - 10:00 AM)

9:00 AM - 9:30 AM

CURRENT THERAPEUTIC INTERVENTION FOR OSA: HOW EFFECTIVE ARE THEY? Agnes Tirona-Remulla, M.D. (Philippines)

A brief summary of treatment interventions for obstructive sleep apnea in adults and current best

evidence on each one’s effectivity will be presented. Interventions will include conservative/lifestyle

changes, positive airway treatments, surgery, pharmacotherapy and recent novel therapies.

9:30 AM - 10:00 AM

ORAL APPLIANCES FOR OSA Emma Natividad, M.D. (Philippines)

The role of dentist in OSA is to assess and observe if patients have small jaws. The position of the

jaws have a consequent effect on the size of the airway/ oropharyngeal space. An undergrown small jaw

can result in a small airway that is more easily blocked when a sleeping jaw drops. Compressed and

crowded throat tissues can choke a sleeper several times. In line with this, we determine the different

factors for narrow, retrussive arches particularly the mandible; malocclusion which is abnormal relation

of teeth if not corrected can lead to OSA.

There's linkage between TMD (Temporomandibular Joint Disorder) to OSA. Articular Disk

Displacement and malocclusion can cause airway to become retruded or collapsed, resulting in sleep

disordered breathing disorders. Treating TMJ pain and sleep disordered breathing calls for elements of

both orthodontics and sleep disorders dentistry which includes oral appliance therapy e.g. mandibular

repositioning devices. These are removable appliances worn at night during sleep fixated to the upper

and lower teeth by various means and can be adjusted so as to advance the mandible up to 8 mm.

(average of 3-5mm). The amount of protrusion adjusted to meet the patient's therapeutic requirements,

comfort and tolerance. It offers several advantages over other methods of treating common upper

airway disorders such as snoring and OSA, high patient acceptance, non-invasive nature, cost

effectiveness, and increased patient compliance.


PLENARY 5: Rhinology April 16, 2016 (10:15 AM - 11:15 AM)

10:15 AM - 10:35 AM

SCIT & SLIT FOR ALLERGIC RHINITIS

De-Yun Wang, M.D., PhD (Singapore)

10:35 AM - 10:55 AM

PEDIATRIC CHRONIC SINUSITIS: WHAT THE LITERATURE SHOWS, AND HOW I PRACTICE


Pediatric sinusitis is a commonly diagnosed clinical scenario in the pediatricians office but the

diagnosis of a “sinus infection” in children is nuanced. Rhinorrhea in children is a very common,

multifactorial symptoms that requires a significant amount of sleuthing to appropriately attribute the

origin. In the setting of recurrent upper respiratory infections in a pediatric population, particularly

children in child care, the chronicity of illness is hard to discern one continuous illness from recurrent

illnesses. The cost to families, the healthcare system and to society due to missed work is enormous, and

a pragmatic, evidence-based approach is warranted. There are some data which reliably guide the initial

management of pediatric sinusitis, however the treatement of pediatric chronic sinusitis, a relatively

uncommon problem, needs to be thought through. There are clear roles for both medical and surgical

care, and shared decision making with the families is paramount. The advent of newer, “less invasive”,

approaches to chronic pediatric sinus disease have also changed the paradigm in some centers.

10:55 AM - 11:15 AM

BALLOON SINUPLASTY Benjamin S.A. Campomanes Jr., M.D. (Philippines)


PLENARY 6: Maxillofacial Surgery April 16, 2016 (11:15 AM - 12:15 PM)

11:15 AM - 11:35 AM

NEW DEVELOPMENTS & INNOVATIONS IN MAXILLOFACIAL SURGERY Peter Aylifee, M.D. (United Kingdom)

11:35 AM - 11:55 AM

UPDATE ON CLEFT LIP AND PALATE SURGERY: FROM DATA TO OUTCOMES

Steve Lawrence Goudy, M.D. (USA)

Cleft lip and palate is the most common craniofacial anomaly, occurring in up to 1 in 700 live

births. These patients suffer from life long care, and understanding the latest, most up to date

techniques for repair is required. Many of the surgical approaches to cleft lip and palate repair have

remained constant, however there are nuances and modifications to each of these procedures. Post

operative complications also occur commonly in this patient population due to poor oral hygiene and

ongoing wound contamination and trauma due to saliva and feeding. Novel approaches to reduce

complications, improve outcomes and decrease the need for additional surgical procedures are being

adopted. Future state of cleft care may involve the use of developing biologic therapies.

11:55 AM - 12:15 PM

MAXILLOFACIAL RECONSTRUCTION Peter Aylifee, M.D. (United Kingdom)


PLENARY 7: Head & Neck Surgery April 16, 2016 (1:45 PM - 3:15 PM)

1:45 PM - 2:05 PM

THE ROLE OF TECHNOLOGY IN PATIENT SPECIFIC MEDICINE: TRANS-ORAL

ROBOTIC SURGERY AND MEDICAL MODELLING FOR BONY RECONSTRUCTION Michael V. Medina, M.D. (USA)

One of the new concepts emerging in medicine is the individualization of patient care. In head

and neck oncology, for decades treatment was compartmentalized and based on staging with most

advancements made on non-surgical treatment and reconstructive techniques.

Trans-oral Robotic oropharyngeal and laryngeal surgery brought back surgery as an option for

primary treatment. It offers for select patients the ability to individualize the patient’s treatment by a

pathology driven plan. Select stage 1-3 patients, instead of receiving up-front radiation therapy or

concomitant chemo-radiation, may end up with surgery only, a lower dose of radiation or a change in

the radiation treatment fields.

Reconstructive surgery for head and neck malignancy developed with micro-vascular flap

reconstruction of defects. Recently medical modelling refined this by creating pre-operative treatment

plans and osteotomy cutting guides for both resection of the primary and the planned osteotomies on

the donor bone (fibula) by using the patient’s pre-operative CT of the mandible and fibula. This allows

pre-bending of plates. By this the two teams can proceed independently and the reconstructive team can

work to the point of making the osteotomies and attaching the donor graft to the pre-bent plate prior to

transection of the pedicle. The newest development is the development of milled plates where in the

plates are not bent but actually made in the form as determined by the pre–operative planning. By this

the strength of the plate is not compromised (by bending) and smaller, lower profile plates may be used.


PLENARY 7: Head & Neck Surgery April 16, 2016 (1:45 PM - 3:15 PM)

2:05 PM - 2:30 PM

THE ROLE OF TECHNOLOGY IN THYROID NODULES AND MALIGNANCY:

MOLECULAR TESTING AND CONTINUOUS NERVE MONITORING Michael V. Medina, M.D. (USA)

The management of Thyroid Nodules and Malignancy is undergoing rapid changes in the areas

of diagnostics and it impacts the decision to do surgery in these cases.

One of the things driving this is the relative benign behaviour of well differentiated thyroid

malignancies and this is fully reflected in the changes in the 2015 ATA Guidelines.

Molecular testing has impacted decision making in Thyroid nodules with indeterminate FNA

results with the explicit goal of preventing unnecessary surgery.

Intra-operative nerve monitoring has been shown to have benefit in sub-group analysis of high

risk patients. Recently continuous intra-operative nerve monitoring was introduced as a better way to

monitor the nerve compared to intermittent stimulation.

2:30 PM - 3:15 PM

PANEL DISCUSSION: SYNOVIAL SARCOMA OF THE HYPOPHARYNX Arsenio Claro A. Cabungcal, M.D. (Philippines) Erland S. del Rosario, M.D. (Philippines)

Katrina P. Ferrera, M.D. (Philippines) Michael Mejia, M.D. (Philippines)

The Role of Chemotherapy in Synovial Sarcoma of the Hypopharynx

Histologic subclassification of soft tissue sarcomas have allowed clinicians to determine general

response to treatment. Synovial sarcoma, a rare type of soft tissue sarcoma, is known to be highly

chemosensitive. However due to the rarity of the disease, data for the use of chemotherapy is extrapo-

lated from studies done in soft tissue sarcoma in general outside the head and neck region. Adjuvant

chemotherapy presents no clear survival benefit but suggest improved local control rates. The role of

neoadjuvant chemotherapy remain to be undefined. Careful patient selection is warranted for both

settings.


PLENARY 8: Facial Plastic

April 16, 2016 (3:30 PM - 5:00 PM)

3:30 PM - 4:00 PM

BOTULINUM TOXIN IN ORL Jaime Anthony A. Arzadon III, M.D. (Philippines)

The speaker will be discussing some new insights on the use of Botulinum Toxin A (BTXA) for

facial rejuvenation and other clinical applications in Otolaryngology. Throughout the years, new

indications are surfacing ranging from dystonias to cosmetics. However we simply cannot ignore the

fact that BTX A use has been closely associated to Facial Aesthetics.

Although many of the uses of BTXA are throughout the body, a majority of indications for use

are still within the Head & Neck region. This makes learning and understanding its nature and

application, imperative in the ENT practice.

4:00 PM - 4:30 PM

F-POP: FACIAL PLASTIC OFFICE PROCEDURES Joseph Amado C. Galvez, M.D. (Philippines)

4:30 PM - 5:00 PM

A DECADE OF GORETEX RHINOPLASTY IN THE PHILIPPINES Eduardo C. Yap, M.D. (Philippines)


PLENARY 9: Otology

April 17 2016 (9:00 AM - 10:30 AM)

9:00 AM - 9:20 AM

DECREASING THE INCIDENCE OF AOM Maria Rina Reyes-Quintos, M.D. (Philippines)

Acute Otitis Media (AOM) is defined as an inflammation of the middle ear with middle ear fluid

and signs and symptoms of ear infection. It is one of the most common cause of visits to the doctor and

antibiotic prescriptions. Will knowing the risk factors for AOM and the development of vaccines that

can target its cause decrease the incidence of AOM?

9:20 AM - 9:45AM

NOISE INDUCED HEARING LOSS & TINNITUS PREVENTION WORKS William Hal Martin, M.D., PhD (Singapore)

Noise induced hearing loss and tinnitus commonly occur together and are both likely to be

linked to the same cause of cochlear sensory cell damage and subsequent neural degeneration. The

cause can be a single, high-level acoustic event or prolonged exposures over several years. The good

news is that nearly all occurrences of noise induced hearing loss and related tinnitus are completely

preventable through simple precautionary measures. Dangerous Decibels® is an international

programme established to reduce the incidence of noise induced hearing loss and tinnitus. Over the past

15 years, the programme has developed, evaluated interventions that have been shown to be effective at

changing knowledge, attitudes and behaviours related to sound exposure and appropriate use of

hearing protective strategies. Hearing loss and tinnitus prevention are an important part of every audi-

ology practice. This will be an interactive demonstration of fun but effective hearing loss and tinnitus

prevention activities.


PLENARY 9: Otology

April 17 2016 (9:00 AM - 10:30 AM)

9:45 AM - 10:10 AM

TINNITUS: HOW TO START A MANAGEMENT PROGRAM William Hal Martin, M.D., PhD (Singapore)

It is likely that a substantial number of your patients complain of tinnitus. You are a competent

clinician but never had much training in tinnitus management. How do you start a tinnitus management

programme? What equipment, materials, resources and collaborations do you need to start providing

tinnitus evaluations and care? Equipment present in most clinical settings and resources available online

(even for free) can provide you with enough materials to begin offering help to individual with tinnitus.

The majority of those who are troubled by tinnitus can be provided relieve with instrumentation

available to the clinician, smart phone apps and other devices. Step-by-step direction for management

of mild to moderate tinnitus conditions can be directed through guides like the Progressive Tinnitus

Management system. As your programme grows you will need to build collaborative relationships

with other professionals who can address parallel, confounding issues that act as obstacles to tinnitus

relief.


PLENARY 9: Otology

April 17 2016 (9:00 AM - 10:30 AM)

10:10 AM - 10:30 AM

STRIDES AT HOME: HISTORY & UPDATES ON NEWBORN HEARING SCREENING IN

THE PHILIPPINES Rosario R. Ricalde, M.D. (Philippines)

In 2007, a Task Force was created by PSO-HNS, which researched the benefits of universal

newborn hearing screening. That same year, the 1st Collaboration for Newborn Hearing Screening

Advocacy (CONHSCA) was held, which provided a venue for various stakeholders to convey their

activities, practices and opinions.

In June 12, 2009, RA 9709 or the Universal Newborn Hearing Screening and Intervention Act of

2009 was signed into law which established a program for prevention, early diagnosis and intervention

of hearing loss, requiring all newborns to undergo hearing screening. In June 28, 2009, the Newborn

Hearing Screening Reference Center was created to serve as the technical arm and collaborator of the

Department of Health. Subsequently, Philhealth circular No. 011-2011 was published stating the

mechanism for claims for newborn hearing screening. In March 31, 2014, DOH Department Circular

2014-0150, the Guidelines for the Universal Newborn Hearing Screening Program Implementation was

published.

During the 6th CONHSCA on December 03, 2012, the Category A Newborn Hearing Screening

Personnel Certifying Course which aims to standardize how newborn hearing screening should be

performed, results documented and conveyed was field tested. As of November 29, 2015, there are 614

certified hearing screening personnel in 253 facilities nationwide.

In September 2013, a research grant was given by the PSO-HNS though the recommendation of

PANORS to do a study entitled “Initial program implementation of the Universal Newborn Hearing and

Intervention Act of 2009 (RA 9709)”. The NHS Registry Card, database website

www.newbornhearingscreening.ph and tablet application were created using this grant.


PLENARY 10:

April 17 2016 (10:45 AM - 12:15 PM)

10:45 AM - 11:15 AM

MANAGEMENT AND PREVENTION OF MORBITIES OF SILICONE INFECTION OR

SILICONOMA Corazon Collantes-Jose, M.D. (Philippines)

One the most in demand silicone oil injection in the early seventies and with no let up to the

present time rampantly use by pseudo doctors and beauticians for instant beauty like noselift, facelift,

fillers etc. This silicone oil cause granulomas resulting to multiple deformities. The only treatment so far

is excision of siliconoma that cause irregularities, so I devise my on technique that will minimize

deformities with amazing results. Its mini liposuction with the use of small canulae followed by facelift

using combination short SCAR FACE LIFT of Dr Tonnard and SMAS. RESULT IS VERY

SATISFACTORY WITH NO COMPLICATIONS.

11:15 AM - 11:45 AM

LIFESTYLE MODIFICATION FOR OSA

Michael Alexius A. Sarte, M.D. (Philippines)

Obstructive sleep apnea (OSA) since its discovery has been undergoing dynamic changes in the

evaluation and management. However, as it is apparently turning out to be a lifelong condition along

with hypertension and diabetes mellitus, environmental support from guided weight management to

alcohol control has proven to be invaluable in controlling the disorder.


PLENARY 10:

April 17 2016 (10:45 AM - 12:15 PM)

11:45 AM - 12:15 PM

SAFETY IN THE WORKPLACE: SCREENING FOR OSA Virginia S. De los Reyes, MD, MHPEd, FPSSM, DWASM (Philippines)

Good sleep is essential for health and wellbeing yet millions of people don’t get enough. Long

work hours may contribute to chronic sleep loss, which may in turn result in work impairment. Risk for

sleep disorders also substantially increases the likelihood of negative work outcomes, including

occupational accidents, and absenteeism. Most workers with sleep disorders however go undiagnosed

and untreated. The result is thousands of unnecessary workplace accidents, injuries and deaths.

Obstructive sleep apnea is one of these sleep disorders that is commonly overlooked and

neglected. OSA is strongly linked to a range of serious health conditions including high blood pressure,

stroke, obesity, diabetes, ischemic heart disease and mood disorders as well as increased risk for

accidents.

For high risk organisations, managing sleep disorders such as OSA and workplace fatigue is now

recognised as essential. In the US, around 24% of men, 9% of women, and up to 28% of transport drivers

have sleep apnea. The benefits of implementing sleep screening programs are therefore considerable.

Prevention costs are minimal compared to the costs of accidents, loss of life, lost productivity, clean up,

equipment damage and loss of reputation. Checking for severe snoring, apnea during sleep and

increased BMI have been found to be useful as screening tools for OSA. If given treatment, employees

with OSA can continue in their job roles and are no more at risk than employees without sleep disorders.


PLENARY 11:

April 17 2016 (2:15 PM - 3:35 PM)

2:15 PM - 2:40 PM

PREVENTING FOREIGN BODY ASPIRATION & INGESTION Mary Jane C. Tipayno-Lubos, M.D. (Philippines)

"'Tis better to be safe than be sorry". Aspiration and Ingestion of foreign bodies has time and time

again proven to be a dreadful and deadly source of complications especially among the youngest group

of our patients. Time tested simple and practical measures need to be implemented in every home ,

school or any environment where children are expected to be.

2:40 PM - 3:05 PM

TAKING STEPS TOWARDS CLEANER AIR AND A HEALTHIER NOSE Ma. Lourdes B. Enecilla, M.D. (Philippines)

Despite advances in medical technology and therapeutics, we still face the increasing burden of

cardiorespiratory disease. Many studies have shown the causal relationship between air pollution and

cardiorespiratory disease. According to the WHO, in 2012 outdoor air pollution caused an estimated 3.7

million premature deaths worldwide. A vast majority of these deaths occurred in the Western Pacific

and Southeast Asian regions. The nose serves as our first defense against air pollution but in the face of

such a ubiquitous and dominating enemy, it can falter and fail. Many take for granted nasal diseases not

realizing it may be a warning of worse things to come. As otorhinolaryngologists, we have the oppor-

tunity to catch the effects of air pollution early and educate our patients. In addition, as vanguards for

human health, we should not just treat disease but should also address the cause and take steps toward

preventing disease. Thus, it is part of our mandate to actively take steps toward decreasing air pollution

and thus improving health for all.


PLENARY 11:

April 17 2016 (2:15 PM - 3:35 PM)

3:05 PM - 3:35 PM

WHEN THE VOICE FAILS: IDENTIFYING & ADDRESSING FACTORS THAT

COMPROMISE VOICE USE IN THE WORKPLACE

Carla Krishnan A. Cuadro, MRS-SP, CSP-PASP (Philippines)

Frederick Y. Hawson, M.D. (Philippines)

Melfred L. Hernandez, M.D. (Philippines)

Fortuna Corazon A. Aberin-Roldan, MD (Philippines)

Professionals whose careers depend on their voice are often distressed when the main tool of

their trade fails to return to its normal quality after a considerable length of time. Voice disorders in this

population are often secondary to a combination of poor awareness of how voice should be produced,

vocally demanding workplace setups, and compromised vocal hygiene. Determining the effects of

internal vs. external factors can enable both the clinician and the client understand to what extent the

voice can adjust in the midst of work-related stress.


PLENARY 12: April 17 2016 (3:50 PM - 5:30 PM)

3:50 PM - 4:15 PM

PHYSICIANS’ RIGHTS Atty. Teresa Paz G. Pascual, M.D. (Philippines)

4:15 PM - 4:40 PM

SENTINEL & ADVERSE EVENTS: AVERTING A CRISIS Atty. Karen Jiz, M.D. (Philippines)

Sentinel and adverse events are incidents in which harm resulted to a person receiving health

care . They may range from minor events to catastrophic circumstances. The consequence can be dis-

tressing to any healthcare provider. How should we deal with this events?


PLENARY 12: April 17 2016 (3:50PM - 5:30 PM)

4:40 PM - 5:05 PM

INFORMED CONSENT Atty. Ivy D. Patdu, M.D. (Philippines)

The basis for obtaining informed consent is respect for a patient’s right to self-determination.

Informed consent is important in cases where a patient will undergo a procedure or treatment, including

use of blood and blood products. There is informed consent if the patient is made to understand the

proposed management, the material risks, alternatives and its consequences, and the patient has the

capacity to make and communicate a decision. The duty of obtaining consent is imposed by law on the

physician. Failure to obtain consent may become the basis of medical liability. A hospital should

implement a policy for obtaining informed consent covering key areas such as who will obtain consent

and the procedure if the patient is unable or incapacitated to give consent, when consent is required, and

how the consent will be obtained, including documentation requirements. The goal is to empower the

patient to make decisions on his or her own health and well-being.

5:05 PM - 5:30 PM

UPDATES ON MEDICAL MALPRACTICE/ BREACH OF CONFIDENTIALITY Atty. Joel U. Macalino, M.D. (Philippines)


SPECIAL SYMPOSIUM April 17 2016 (1:45 PM - 2:15 PM)

NASAL STEM CELL RESEARCH: UNDERSTANDING THE ROLE OF NASAL

EPITHELIUM IN COMMON NASAL DISEASES De-Yun Wang, (Singapore)

The nose together with the paranasal sinuses has an approximate surface area of 100 to 200 cm2

in adults, which is lined with pseudostratified columnar ciliated epithelium. It serves several important

physiological functions such as conditioning and filtration of the inspired air and the provision of end

organ for the sense of smell. It is also a physical and immunological barrier as it is the first site of interac-

tion between the host tissue and foreign invaders (viruses, bacteria, and allergens). Airway epithelium is

one of the central players in respiratory disease, but it is notoriously difficult to distinguish between

cause and effect with regard to the epithelium’s role in the context of diseases. It is therefore important

to gain insights into the mechanism by which human nasal epithelial cells respond to various pathogens

or antigens, where such an event might take place in nature. Recently, we have been successful in

isolating adult human nasal epithelial stem/progenitor cells from nasal biopsies of healthy subjects and

patients with chronic rhinosinusitis with nasal polyps. Single cell derived colonies stain uniformly for

basal cell markers such as p63 and keratin 5 (Krt5), and about 80% of the colonies show long-term

self-renewal potential with an estimated 20-50 additional doublings, while maintaining an immature

phenotype. Lineage potential has been assessed through multiple differentiation assays, in which the

pedigree lines developed from single cells can differentiate into stratified mucociliary airway epithelium

composed of both ciliated columnar cells and goblet cells. It opens up many research possibilities to

understand the molecular mechanisms and pathways underlying both healthy and diseased nasal

epithelium and to identify more targeted and cellular therapies for common nasal diseases.


DINNER SYMPOSIUM 2 April 17 2016 (7:30 - 8:30 PM)

TREATMENT OF ALLERGIC RHINITIS: A REVIEW OF THE NEWEST ANTIHISTAMINE

DRUG BILASTINE De-Yun Wang, M.D. (Singapore)

Allergic rhinoconjunctivitis (AR) is a common condition that affects a significant proportion of

the global population, across all age groups and is often a life-long condition. Its impact on direct and

indirect healthcare costs is significant and it negatively impacts patients’ quality of life, work

performance and social functioning. Pharmacological agents available for treatment of AR include

topical steroids, antihistamines, sodium cromoglycate, and decongestants. As introduced in the 1980s,

second-generation H1-antihistamines are recommended by international guidelines for treatment of AR

as they are safe and efficacious. They should be considered as a first-choice treatment due to their

favorable risk/benefit ratio, the satisfactory pharmacokinetics and the clinical efficacy than the older gen-

eration of H1-antihistamines.

Bilastine, a newly introduced second-generation H1-antihistamine for AR and urticaria, has

shown significant clinical efficacy with a rapid onset and long duration of action, considerably less

sedative potential with no interact with CYP450 and no cardiac side-effects even in up to fourfold

dosage. The therapeutic profile advantages of bilastine in this setting are likely to engender considerable

prescriber confidence in any decision to ‘push’ the standard dosage upwards. Such prescriber confidence

in dosage ‘up-escalation’ is less likely to manifest for other second-generation antihistamines. In

summary, the many clinical benefits and positive overall benefit–risk ratio of bilastine confirm that this

compound has a forerunning place in therapy among second-generation H1-antihistamines in the man-

agement of AR and other allergic diseases.


JAMES BURNS, MD (USA)

Center for Laryngeal Surgery & Voice

Rehabilitation

One Bowdoin Square, 11th Floor-

Boston, Massachusetts 02114

617-726-1444

[email protected]

WILLIAM HAL MARTIN, MD (Singapore)

Professor, Director of M.Sc. Audiology

Programme, Department of Otolaryngology,

National University of Singapore

Co-Director Dangerous Decibels

[email protected]

www.dangerousdecibes.org http://

medicine.nus.edu.sg/dgms/audiology/

REGIE LYN SANTOS-CORTEZ, MD

(USA)

Asst. Professor, Center for Statistical

Genetics, Department of Molecular

and Human Genetics, Baylor College

of Medicine

+1-713-7986844

[email protected]; san-

[email protected]

MICHAEL V. MEDINA, MD (USA)

Otolaryngologist-Head and Neck Surgeon,

Cleveland Clinic Florida

[email protected]

www.clevelandclinicflorida.org

DE-YUN WANG, MD, PHD (Singapore)

Research Professor (Tenure) and Di-

rector of Research, Department of

Otolaryngology at the National Uni-

versity of Singapore

Director of Research of the National

University Health System (NUHS)

STEVEN L. GOUDY, MD (USA)

Associate Professor of Otolaryngology and

Pediatrics Vanderbilt

Affiliate Appointment Georgia Institute of

Technology Petite Institute

Atlanta, GA 30322

404-785-2000

[email protected]

FOREIGN SPEAKERS


GRETCHEN NAVARRO-LOCSIN MD

Vice Chair, Dept of ORL-HNS, St.

Luke’s Medical Center – Quezon City

Head, Paediatric ORL, Dept of ORL-

HNS, St. Luke’s Medical Center –

Quezon City

EMMA NATIVIDAD, MD

AGNES T. REMULLA, MD

Clinical Associate Professor, UP

College of Medicine

Assistant Chair for Teaching,

Department of Otorhinolaryngology,

UP-PGH

[email protected]

JAIME ANTHONY A. ARZADON III, MD

Head, Section of Facial Plastic Surgery, Asian

Hospital & Medical Center

President, Philippine Academy of Facial

Plastic & Reconstructive Surgery (PAFPRS)

[email protected]

ANN MARGARET V. CHANG, MD

St. Luke’s Medical Center Quezon

City: Consultant Pathologist and Edi-

torial Board Member SLMC

Healthcare Journal

St. Luke’s College of Medicine:

Assistant Professor

[email protected] ;

[email protected]

KATRINA P, FERRERA, MD

Residency Training Officer in Medical

Oncology, University of the East Ramon

Magsaysay Memorial Medicial Center

[email protected]

CORAZON COLLANTES-JOSE, MD

President – Philippine Society of Cos-

metic Surgery (PSCS)

Founding President - Philippine Socie-

ty of Liposuction Surgery, Inc. (PSLSI)

Founding President - Asian Pacific

Academy of Cosmetic Surgery

(APACS)

MA. LOURDES B. ENECILLA, MD

Active Consultant - St. Luke’s Medical

Center- Global City

Active Consultant - Asian Hospital and

Medical Center

Affiliate Consultant - St. Luke’s Medical

Center – Quezon City

[email protected]

LOCAL SPEAKERS


MARY JANE TIPAYNO-LUBOS, MD

Medical Specialist, Training Officer,

BGH-MC

074-442 -4216

[email protected]

CARLA KRISHNAN CUADRO, MR-SP, CSP-

PASP

Consultant speech-language pathologist

Voice, Swallowing & Sinus Center, St. Luke’s

Medical Center

Memory Center, St. Luke’s Medical Center

+63.917.525.8697

[email protected]

ATTY. IVY D. PATDU, MD

Deputy Privacy Commissioner ,

National Privacy Commission

[email protected]

MICHAEL ALEXIUS A. SARTE, MD

Consultant Director, The Medical City

Residency Training Officer, Rizal Medical

Center

706-0109

[email protected]

MARIA RINA REYES-QUINTOS, MD

Deputy Executive Director, NIH, UP

Manila

Program Director: Hearing and

Dizziness Center in The Medical City

The Medical City, MATI Building

6356789

VIRGINIA S. DE LOS REYES, MD, MHPEd,

FPSSM, DWASM

President , Philippine Society of Sleep

Medicine

3721981

ginadelosreyes@hotmailcom

ROSARIO R. RICALDE, MD

Newborn Hearing Screening

Reference Center

Liaison to the Director, National

Institutes of Health, UP Manila,

09321504215

[email protected]

ATTY. KAREN JIZ, MD

Director, Clinical Investigation & Analysis,

The Medical City

Partner, Jiz Law Offices

Faculty, De La Salle College of Law

Consultant, Dept. of Anesthesiology Rizal

Medical Center

[email protected]

LOCAL SPEAKERS


A. Menarini Philippines, Inc.

4th Floor W Office Building 11th Avenue corner 28th St.

Bonifacio High Street, Bonifacio Global City, Taguig

Phone: (+63 2) 333-3895

Mobile No.: 0915-1143535

E-mail: [email protected]

Ms. Rodalie Grace ‘Bannie’ P. Baluyut

Senior Brand Manager

A. Menarini Philippines, Inc. - Kamillosan

4th Floor W Office Building 11th Avenue corner 28th St.

Bonifacio High Street, Bonifacio Global City, Taguig

Phone: (+63 2) 333-3975

Mobile No.: 0906-5598605


Ma. Kassandra Jamias

Brand Manager

Abbott Laboratories

8/F Venice Corporate Center, No. 8 Turin St.

McKinley Town Center, Fort Bonifacio, Taguig City

Phone: (63-2) 822-2688

Fax: (63-2) 894-1071


Ms. Rosette G. Espiritu

CME Associate Officer

ADP Pharma Corporation

23/F The Taipan Place, F.Ortigas Jr. Road

Ortigas Center, Pasig City

Phone: (63-2) 988-2538

Mobile No.: 0920 9882709


Ms. Jenelyn DJ. Eugenio

CME Management Associate

Allmed Instruments Medical System (AIMS)

Unit 2A Aiza Building 134 Mindanao Avenue

Brgy. Bahay Toro, Quezon City

Phone: (63-2) 453-7454

Telefax: (63-2) 930-8708

Mobile No.: 0922-8975304


Ms. Rosellyn Mariano

Secretary

American Technologies Inc.

5 Ideal St. Addition Hills Mandaluyong City

Phone: (63-2) 584-0000

Fax: (63-2) 584-6868


Ms. Alma Postrano

Head, Marketing Department

Beaumed Inc.

106 Unit 204 FRDC Bldg., E Rodriguez Jr. Avenue

Ugong, Pasig City

Phone: (63-2) 470-1261

Mobile No.: 0915-9389530


Ms. Jacqueline Reniedo

Sales Manager

Biomedis Inc.

G/F Unilab Building

66 United Street, Mandaluyong City

Fax: (63-2) 812-1252

Mobile No.: 0917-8209035


Mr. Jeremy Ross A. Lim

CMG Specialist

mailto:[email protected]





Celsus Pharmaceuticals Phils. Inc.

115 Scout Rallos corner 11th Jamboree Streets

Sacred Heart, Quezon City 1103

Phone: (63-2) 928-8208

Fax: (63-2) 928-0815

Mobile: 0920-9026548


Mr. Andres G. Fernandez

National Sales Manager

DR-KIM (The Best Headlight and Loupe in the

World)

#213 Ace Gwangmyeong Tower, 108 Haan-ro

Gwangmyeong-si, Gyeoggi-do 423-798 Korea

Phone: +82-2-2611475

Fax: +82-2-26114758

E-mail: [email protected]; Website: www.dr-

kim.net

Chris Kim

Manager

Dubbel Medical Corporation

Unit 202 Ablaza Bldg., 117 E. Rodriguez, Sr. Ave.

Quezon City

Fax: (63-2) 740-0713

Mobile: 0922-8696065

Email:[email protected];l

[email protected]

Ms. Annabelle A. Jorda

Chief Finance Manager

Ear Diagnostics Inc.

G/F Cosmopolitan Church corner Apacible

Taft, Ermita, Manila

Phone: (63-2) 536-7772; (033) 337-1069

Fax: (63-2) 567-1105

Mobile No.: 0922-8221584


Dr. Rodolfo B. Dela Cruz

President

Easmed Medical Supplies, Inc.

Unit 506AThe Richmonde Plaza, 21 San Miguel Ave.


Phone: (63-2) 634-0441; 343-8211

Fax: (63-2) 470-6518

Mobile No.: 0922-8678211


Ms. Lisa Marie D. Bon

Accounts and Admin Executive

Fernando Medical Enterprises, Inc. (FMEI)

3rd Floor MHI Bldg., No. 2-A New York Street

Brgy. Immaculate Conception, Cubao, Quezon City

Phone: (63-2) 727-1521; 727-1532

Fax: (63-2) 727-1489

Mobile No.: 0917-5636797


Mr. Sonny D. Feliciano

Product Manager

First Associated Medical Distribution Co., Inc.

(FAMED)

FCI Corporate Center, 1814 Philip Street

Multinational Village, Brgy. Moonwalk, Parañaque

City

Phone: (63-2) 826-8523

Fax: (63-2) 788-0080

Mobile No.: 0917-8631225


Ms. Jacque M. Eusebio

Sales Manager



http://www.dr-kim.net

http://www.dr-kim.net





GlaxoSmithKline Philippines, Inc.

2266 Chino Roces Avenue, Makati City

Phone: (63-2) 892-0761

Mobile No.: 0917-8897027


Mr. Charles Arevalo

CME Officer

Glenmark Philippines, Inc.

310 Lapanday Center, 2263 Pasong Tamo Ext.

Makati City

Phone: (63-2) 839-2879

Mobile No.: 0917-8118269


Mr. Manuel Contreras, Jr.

Brand Manager

Great Reconstruction Surgicals, Inc.

Rm. 501-C Culmat Bldg., 1270-1330

E. Rodriguez Sr. Avenue, Quezon City

Telefax: (63-2) 725-0867

Mobile No.: 0917-5411234


Ms. Zeth San Antonio

Corporate Secretary

Healthworld International Philippines Corporation

421 Quirino Ave., La Huerta, Parañaque City

Phone: (63-2) 829-0175

Fax: (63-2) 826-6770

Mobile No.: 0922-8496753


Ms. Mengie Cabanlit

Sales Manager

Hi-Eisai Pharmaceutical Inc.

20th Floor Multinational Bancorporation Centre

6805 Ayala Avenue, Makati City

Phone: (63-2) 887-1075

Fax: (63-2) 887-5172

Mobile No.: 0998-5314596


Ms. Macky Quidato

Brand Manager

Homecare Medical

1850 Felix Huertas St., Sta. Cruz, Manila

Phone: (63-2) 313-5450; 313-8650; 998-1615

Mobile No.: 0917-6694271; 0936-9518000


Mr. Roy H. Almario

Operation Manager

Hyphens Pharma Philippines, Inc.

16th Floor Unit 1606 Orient Square Bldg.

Ortigas Jr. Road, Ortigas Centre, Pasig City

Phone: (63-2) 706-3386

Fax: (63-2) 706-3391

Mobile: 0905-9991189


Ms. Josiephine Sac-Mantoya

Marketing Manager

iNova Pharmaceuticals

Unit 2802 Penthouse One Global Place 25th Street

cor. 5th Ave., BGC Taguig City, 1634

Phone: (63-2) 737-5100

Mobile No.: 0917-3285875

Email: [email protected]; [email protected]

Ms. Novelle de Leon-Lopez

Senior Product Manager






Intermed Marketing Philippines, Inc.

15F Paragon Corporate Centre Industry St.

Madrigal Business Park, Ayala Alabang

Muntinlupa City

Mobile No.: 0915-2789635


Mr. Ralph Andrew Romana

Associate Product Manager

IOS Marketing Corporation

647 P. Paterno St., Quiapo, Manila

Phone: (63-2) 733-5445

Fax: (63-2) 733-3767

Mobile No.: 0917-8347912


Ms. Lenlie Villanueva

Sales Head

Iberica-Verheilen Pharmaceuticals Group (IVP

Group)

2204-C 22/F West Tektite Tower, PSE Center


Phone: (63-2) 635-3082; 636-3211

Mobile No.: 0917-8330140


Mr. Christopher T. Ballesteros

District Manager

Justright Pharmaceuticals

#20 Palanza corner Guirayan Streets

Brgy. Doña Imelda, Quezon City

Phone: (63-2) 413-2367 loc. 108

Fax: (63-2) 412-0533

Mobile No.: 0919-9115391


Mr. John Rex V. Hermoso

Product Manager

Karl Storz

Karl Storz Endoscopy Asia Marketing Pte. Ltd

No. 8 Commonwealth Lane #03-02 Singapore 149555

Mobile No.: 0917-8117586


Mr. Paulo San Pedro

Marketing Manager

LeFort Medical Trading Corp.

46 Mayor I.S. Diaz St., Cubao, Quezon City

Mobile No.: 0920-9184159


Ms. Lorie Salazar

Sales Manager

Microlab Phils., Inc.

1157 Rodriguez Avenue, cor. Heneral Lacuña St.

Bangkal, Makati City

Phone: (63-2) 551-3839 loc. 230

Fax: (63-2) 831-9621

Mobile: 0917-8172612

Email: [email protected]

Ms. Bea Andrei V. Mancenido

Business Development Associate

MTC Opto-Medic, Inc.

3rd Floor OHI Bldg., #179 Yakal St.

San Antonio Village, Makati City

Phone: (63-2) 813-1351

Mobile: 0917-6277459


Mr. Emer Alcantara

Manager


Natrapharm, Inc.

The Patriot Bldg. Km. 18 West Service Road

SLEX, Sucat, Parañaque City

Phone: (63-2) 821-7382

Fax: (63-2) 825-9249

Mobile No.: 0917-8747527


Mr. Ferdinand Carmelo F. Samson

Associate Product Manager

Nurture Medical Pharma, Inc.

Capt. Henry Javier cor. Danny Floro St.

Brgy. Oranbo, Pasig City

Fax: (63-2) 738-3074

Mobile No.: 0917-8494336


Mr. Romel T. Bunagan

Product Manager

Pharex Health Corp

Units 101-102, G/F Bldg. Alpha UP-Ayala Land Tech-

noHub Commonwealth Ave., Diliman, Quezon City

Fax: (63-2) 433-8088

Mobile No.: 0998-9651226


Ms. Dei Pantig

Product Manager

Pines Medical Trading

14 A Sunflower St, San Luis Village, Baguio City

Phone: (074) 442-2293

Mobile No.: 0917-6870081


Ms. Jonah W. Deyto

Proprietress

ResWerkes Phils., Inc.

Unit 1001 The Orient Square Building

F. Ortigas, Jr. Rd., Ortigas Center, Pasig City

Phone: (63-2) 470-2931

Fax: (63-2) 470-2809

Mobile No.: 0915-6455542


Mr. Wesley Amancio

Product Specialist

Sandoz Philippines Corporation

7th Floor ARCC Bldg., Salcedo cor. Gamboa St.

Legaspi Village, Makati City

Phone: (63-2) 368-7888

Fax: (63-2) 815-0101

Mobile No.: 0917-8487808 / 0917-7702964


: [email protected]

Ms. Daye Delos Reyes / Sherwin Matibag

Product Manager / CME Manager

Takeda Healthcare (Philippines) Inc.

17th Floor, Zuellig Bldg. corner Paseo de Roxas

Makati Avenue, Makati City

Phone: (63-2) 575-0064

Fax: (63-2) 575-0080

Mobile No.: 0998-8409321


Ms. Camille Reyes

Associate Professional Healthcare Services Manager

The Cathay Drug Company Inc.

2/F Vernida 1 Bldg., 120 Amorsolo St.

Legaspi Village, Makati City

Phone: (63-2) 892-5936

Fax: (63-2) 818-6739

Mobile No.: 0917-8812978


Ms. Maria Agnes Ramos

CME Coordinator





United American Pharmaceuticals, Inc.

132 Pioneer Street LVP Compound, Mandaluyong

City

Phone: (63-2) 858-1000

Fax: (63-2) 635-3581


: [email protected]

Mr. Rinaldo C. Enriquez l Mr. Fernando A. Flores

UAP-Product Management Group

United Laboratories, Inc.

#66 United St., Mandaluyong City

Phone: (63-2) 858-1000 local 1970


Website: www.unilab.com.ph

Mr. Rainier S. Herradura

Professional Relations Management Division

Variance Trading Corporation

57-A Maliksi St., Brgy. Pinyahan, Quezon City

Fax: (63-2) 990-0600

Mobile No.: 0995-4298530

E-mail:

[email protected]

Mr. Henry S. Dela Cruz

Business Unit Manager

Westmont Pharmaceuticals

4th Floor, Bonaventure Plaza, Ortigas Avenue

Greenhills, San Juan City

Phone: (63-2) 858-1722 loc. 5123

Mobile: 0917-8209625


Ms. Jennifer Lim

CMG Officer



http://www.unilab.com.ph


The PSO - HNS would like to thank the following for their continuing support.

Documents

PSO HNS Jubilee Midyear Convention · PSO-HNS Jubilee Midyear Convention O n behalf of the Board of Trustees of the Philippine Society of Otolaryngology - Head and Neck Surgery let